Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Trends in Endocrinology and Metabolism: TEM|February 5, 2013
GUCY2C: at the intersection of obesity and cancerGilbert W Kim, Jieru E Lin, Scott A WaldmanArchives of Neurology|June 24, 2004
No mutations in CACNA1A and ATP1A2 in probands with common types of migraineJoanna C Jen, Gilbert W Kim, Kristen A Dudding, et al.Expert Opinion on Drug Discovery|April 30, 2013
New advances in models and strategies for developing anti-obesity drugsGilbert W Kim, Jieru E Lin, Erik S Blomain, et al.Molecular Aspects of Medicine|October 30, 2012
Obesity pharmacotherapy: what is next?Francheska Colon-Gonzalez, Gilbert W Kim, Jieru E Lin, et al.Expert Review of Clinical Pharmacology|June 14, 2011
Regulation of appetite to treat obesityGilbert W Kim, Jieru E Lin, Michael A Valentino, et al.The Journal of Clinical Investigation|August 26, 2011
A uroguanylin-GUCY2C endocrine axis regulates feeding in miceMichael A Valentino, Jieru E Lin, Adam E Snook, et al.Cancer Research|October 3, 2013
Intestinal GUCY2C prevents TGF-β secretion coordinating desmoplasia and hyperproliferation in colorectal cancerAhmara V Gibbons, Jieru E Lin, Gilbert W Kim, et al.Cancer Research|January 17, 2016
Obesity-Induced Colorectal Cancer Is Driven by Caloric Silencing of the Guanylin-GUCY2C Paracrine Signaling AxisJieru E Lin, Francheska Colon-Gonzalez, Erik Blomain, et al.Circulation|March 5, 2008
Targeted inhibition of cardiomyocyte Gi signaling enhances susceptibility to apoptotic cell death in response to ischemic stressBrent R DeGeorge, Erhe Gao, Matthieu Boucher, et al.Pageof 1